OTCMKTS:SHPMF

Shanghai Pharmaceuticals (SHPMF) Stock Forecast, Price & News

$1.59

0.00 (0.00%)

(As of 09/28/2023 ET)

Compare

Today's Range: $1.59
▼
$1.59
50-Day Range: $1.56
▼
$1.84
52-Week Range: $1.28
▼
$2.08

Volume: N/A
Average Volume: 3,775 shs
Market Capitalization: N/A

P/E Ratio: 1.70
Dividend Yield: 16.62%
Price Target: N/A

Profile Chart Competitors Financials Headlines Short Interest

About Shanghai Pharmaceuticals

Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

SHPMF Price History

30 days | 90 days | 365 days | Advanced Chart

SHPMF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive SHPMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shanghai Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medical Distribution
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:SHPMF
CUSIP: N/A
CIK: 1570300
Web: www.sphchina.com
Phone: 86-21-6373-0908
Fax: N/A
Employees: 47,811
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 1.70
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Bo Shen (Age 50)
Pres, CFO, Head of the Accounting Department & Exec. Director
Comp: $797.01k

Mr. Yongzhong Li (Age 53)
VP & Exec. Director
Comp: $896.25k

Mr. Tao Zhong (Age 51)
VP, Board Sec. & Joint Company Sec.

Mr. Dongming Li (Age 54)
VP

Ms. Shuai Shao (Age 35)
VP

Dr. Shunjiang Yu
Chief Medical Officer

Mr. Ming Dong (Age 47)
Exec. Director

Ms. Shui Bing Leung A.C.S. (Age 46)
Joint Company Sec.

Ying Ke
Director & Gen. Mang. of R&D Management Center

Linqiong Dong
Securities Affairs Representative

Key Competitors

View All Competitors

SHPMF Stock - Frequently Asked Questions

How have SHPMF shares performed in 2023?: Shanghai Pharmaceuticals' stock was trading at $1.62 on January 1st, 2023. Since then, SHPMF shares have decreased by 2.2% and is now trading at $1.5850.
View the best growth stocks for 2023 here.
Are investors shorting Shanghai Pharmaceuticals?: Shanghai Pharmaceuticals saw a decline in short interest in September. As of September 15th, there was short interest totaling 32,800 shares, a decline of 95.1% from the August 31st total of 665,600 shares. Based on an average trading volume of 3,000 shares, the days-to-cover ratio is presently 10.9 days.
View Shanghai Pharmaceuticals' Short Interest.
Is Shanghai Pharmaceuticals a good dividend stock?: Shanghai Pharmaceuticals (OTCMKTS:SHPMF) pays an annual dividend of $0.26 per share and currently has a dividend yield of 2.01%. The dividend payout ratio is 28.26%. This payout ratio is at a healthy, sustainable level, below 75%.
What is Shanghai Pharmaceuticals' stock symbol?: Shanghai Pharmaceuticals trades on the OTCMKTS under the ticker symbol "SHPMF."

How do I buy shares of Shanghai Pharmaceuticals?: Shares of SHPMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Shanghai Pharmaceuticals' stock price today?: One share of SHPMF stock can currently be purchased for approximately $1.59.
How many employees does Shanghai Pharmaceuticals have?: The company employs 47,811 workers across the globe.
How can I contact Shanghai Pharmaceuticals?: Shanghai Pharmaceuticals' mailing address is Shanghai Pharmaceutical Building, Shanghai, 200020. The official website for the company is www.sphchina.com. The company can be reached via phone at 86-21-6373-0908.

This page (OTCMKTS:SHPMF) was last updated on 9/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial